img

Global Norovirus Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Norovirus Vaccine Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Norovirus Vaccine report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Norovirus Vaccine market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2029. Demand from Hospital and Clinic are the major drivers for the industry.
Norovirus, a human caliciviridae virus, is mainly transmitted through the fecal-oral route and is highly contagious. It has no obvious pathogenicity in healthy people, but can cause serious illness and complications in immunocompromised patients, the elderly and children. It can last for a long time, and the main symptoms of infection are diarrhea and vomiting. Norovirus vaccines can effectively prevent viral infections, but the current existing vaccines fail to meet clinical needs, resulting in a large demand gap. As people's health awareness increases, there will be a huge demand for norovirus vaccines in the future.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Norovirus Vaccine market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Hillevax
Vaxart
Moderna
UMN Pharma
Daiichi Sankyo
Kanghua Biology
Beijing Institute of Biological Products
Zhifei Bio
China Biotechnology Co., Ltd.
North China Pharmaceutical
Segment by Type
Bivalent
Quadrivalent
Hexavalent

Segment by Application


Hospital
Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Norovirus Vaccine market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Norovirus Vaccine, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Norovirus Vaccine industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Norovirus Vaccine in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Norovirus Vaccine introduction, etc. Norovirus Vaccine Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Norovirus Vaccine market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Norovirus Vaccine Market Overview
1.1 Norovirus Vaccine Product Overview
1.2 Norovirus Vaccine Market Segment by Type
1.2.1 Bivalent
1.2.2 Quadrivalent
1.2.3 Hexavalent
1.3 Global Norovirus Vaccine Market Size by Type
1.3.1 Global Norovirus Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Norovirus Vaccine Historic Market Size Review by Type (2018-2024)
1.3.3 Global Norovirus Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Norovirus Vaccine Sales Breakdown by Type (2018-2024)
1.4.2 Europe Norovirus Vaccine Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Norovirus Vaccine Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Norovirus Vaccine Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Norovirus Vaccine Sales Breakdown by Type (2018-2024)
2 Global Norovirus Vaccine Market Competition by Company
2.1 Global Top Players by Norovirus Vaccine Sales (2018-2024)
2.2 Global Top Players by Norovirus Vaccine Revenue (2018-2024)
2.3 Global Top Players by Norovirus Vaccine Price (2018-2024)
2.4 Global Top Manufacturers Norovirus Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Norovirus Vaccine Market Competitive Situation and Trends
2.5.1 Norovirus Vaccine Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Norovirus Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Norovirus Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Norovirus Vaccine Market
2.8 Key Manufacturers Norovirus Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Norovirus Vaccine Status and Outlook by Region
3.1 Global Norovirus Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Norovirus Vaccine Historic Market Size by Region
3.2.1 Global Norovirus Vaccine Sales in Volume by Region (2018-2024)
3.2.2 Global Norovirus Vaccine Sales in Value by Region (2018-2024)
3.2.3 Global Norovirus Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Norovirus Vaccine Forecasted Market Size by Region
3.3.1 Global Norovirus Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Norovirus Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Norovirus Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Norovirus Vaccine by Application
4.1 Norovirus Vaccine Market Segment by Application
4.1.1 Hospital
4.1.2 Clinic
4.1.3 Others
4.2 Global Norovirus Vaccine Market Size by Application
4.2.1 Global Norovirus Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Norovirus Vaccine Historic Market Size Review by Application (2018-2024)
4.2.3 Global Norovirus Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Norovirus Vaccine Sales Breakdown by Application (2018-2024)
4.3.2 Europe Norovirus Vaccine Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Norovirus Vaccine Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Norovirus Vaccine Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Norovirus Vaccine Sales Breakdown by Application (2018-2024)
5 North America Norovirus Vaccine by Country
5.1 North America Norovirus Vaccine Historic Market Size by Country
5.1.1 North America Norovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Norovirus Vaccine Sales in Volume by Country (2018-2024)
5.1.3 North America Norovirus Vaccine Sales in Value by Country (2018-2024)
5.2 North America Norovirus Vaccine Forecasted Market Size by Country
5.2.1 North America Norovirus Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Norovirus Vaccine Sales in Value by Country (2024-2029)
6 Europe Norovirus Vaccine by Country
6.1 Europe Norovirus Vaccine Historic Market Size by Country
6.1.1 Europe Norovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Norovirus Vaccine Sales in Volume by Country (2018-2024)
6.1.3 Europe Norovirus Vaccine Sales in Value by Country (2018-2024)
6.2 Europe Norovirus Vaccine Forecasted Market Size by Country
6.2.1 Europe Norovirus Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Norovirus Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Norovirus Vaccine by Region
7.1 Asia-Pacific Norovirus Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Norovirus Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Norovirus Vaccine Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Norovirus Vaccine Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Norovirus Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Norovirus Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Norovirus Vaccine Sales in Value by Region (2024-2029)
8 Latin America Norovirus Vaccine by Country
8.1 Latin America Norovirus Vaccine Historic Market Size by Country
8.1.1 Latin America Norovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Norovirus Vaccine Sales in Volume by Country (2018-2024)
8.1.3 Latin America Norovirus Vaccine Sales in Value by Country (2018-2024)
8.2 Latin America Norovirus Vaccine Forecasted Market Size by Country
8.2.1 Latin America Norovirus Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Norovirus Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Norovirus Vaccine by Country
9.1 Middle East and Africa Norovirus Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Norovirus Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Norovirus Vaccine Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Norovirus Vaccine Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Norovirus Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Norovirus Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Norovirus Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Hillevax
10.1.1 Hillevax Company Information
10.1.2 Hillevax Introduction and Business Overview
10.1.3 Hillevax Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Hillevax Norovirus Vaccine Products Offered
10.1.5 Hillevax Recent Development
10.2 Vaxart
10.2.1 Vaxart Company Information
10.2.2 Vaxart Introduction and Business Overview
10.2.3 Vaxart Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.2.4 Vaxart Norovirus Vaccine Products Offered
10.2.5 Vaxart Recent Development
10.3 Moderna
10.3.1 Moderna Company Information
10.3.2 Moderna Introduction and Business Overview
10.3.3 Moderna Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Moderna Norovirus Vaccine Products Offered
10.3.5 Moderna Recent Development
10.4 UMN Pharma
10.4.1 UMN Pharma Company Information
10.4.2 UMN Pharma Introduction and Business Overview
10.4.3 UMN Pharma Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.4.4 UMN Pharma Norovirus Vaccine Products Offered
10.4.5 UMN Pharma Recent Development
10.5 Daiichi Sankyo
10.5.1 Daiichi Sankyo Company Information
10.5.2 Daiichi Sankyo Introduction and Business Overview
10.5.3 Daiichi Sankyo Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Daiichi Sankyo Norovirus Vaccine Products Offered
10.5.5 Daiichi Sankyo Recent Development
10.6 Kanghua Biology
10.6.1 Kanghua Biology Company Information
10.6.2 Kanghua Biology Introduction and Business Overview
10.6.3 Kanghua Biology Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Kanghua Biology Norovirus Vaccine Products Offered
10.6.5 Kanghua Biology Recent Development
10.7 Beijing Institute of Biological Products
10.7.1 Beijing Institute of Biological Products Company Information
10.7.2 Beijing Institute of Biological Products Introduction and Business Overview
10.7.3 Beijing Institute of Biological Products Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Beijing Institute of Biological Products Norovirus Vaccine Products Offered
10.7.5 Beijing Institute of Biological Products Recent Development
10.8 Zhifei Bio
10.8.1 Zhifei Bio Company Information
10.8.2 Zhifei Bio Introduction and Business Overview
10.8.3 Zhifei Bio Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Zhifei Bio Norovirus Vaccine Products Offered
10.8.5 Zhifei Bio Recent Development
10.9 China Biotechnology Co., Ltd.
10.9.1 China Biotechnology Co., Ltd. Company Information
10.9.2 China Biotechnology Co., Ltd. Introduction and Business Overview
10.9.3 China Biotechnology Co., Ltd. Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.9.4 China Biotechnology Co., Ltd. Norovirus Vaccine Products Offered
10.9.5 China Biotechnology Co., Ltd. Recent Development
10.10 North China Pharmaceutical
10.10.1 North China Pharmaceutical Company Information
10.10.2 North China Pharmaceutical Introduction and Business Overview
10.10.3 North China Pharmaceutical Norovirus Vaccine Sales, Revenue and Gross Margin (2018-2024)
10.10.4 North China Pharmaceutical Norovirus Vaccine Products Offered
10.10.5 North China Pharmaceutical Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Norovirus Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Norovirus Vaccine Industrial Chain Analysis
11.4 Norovirus Vaccine Market Dynamics
11.4.1 Norovirus Vaccine Industry Trends
11.4.2 Norovirus Vaccine Market Drivers
11.4.3 Norovirus Vaccine Market Challenges
11.4.4 Norovirus Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Norovirus Vaccine Distributors
12.3 Norovirus Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Bivalent
Table 2. Major Company of Quadrivalent
Table 3. Major Company of Hexavalent
Table 4. Global Norovirus Vaccine Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 5. Global Norovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 6. Global Norovirus Vaccine Sales Market Share in Volume by Type (2018-2024)
Table 7. Global Norovirus Vaccine Sales by Type (2018-2024) & (US& Million)
Table 8. Global Norovirus Vaccine Market Share in Value by Type (2018-2024)
Table 9. Global Norovirus Vaccine Price by Type (2018-2024) & (US$/Unit)
Table 10. Global Norovirus Vaccine Sales by Type (2024-2029) & (K Units)
Table 11. Global Norovirus Vaccine Sales Market Share in Volume by Type (2024-2029)
Table 12. Global Norovirus Vaccine Sales by Type (2024-2029) & (US$ Million)
Table 13. Global Norovirus Vaccine Sales Market Share in Value by Type (2024-2029)
Table 14. Global Norovirus Vaccine Price by Type (2024-2029) & (US$/Unit)
Table 15. North America Norovirus Vaccine Sales by Type (2018-2024) & (K Units)
Table 16. North America Norovirus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 17. Europe Norovirus Vaccine Sales (K Units) by Type (2018-2024)
Table 18. Europe Norovirus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 19. Asia-Pacific Norovirus Vaccine Sales (K Units) by Type (2018-2024)
Table 20. Asia-Pacific Norovirus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 21. Latin America Norovirus Vaccine Sales (K Units) by Type (2018-2024)
Table 22. Latin America Norovirus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 23. Middle East and Africa Norovirus Vaccine Sales (K Units) by Type (2018-2024)
Table 24. Middle East and Africa Norovirus Vaccine Sales by Type (2018-2024) & (US$ Million)
Table 25. Global Norovirus Vaccine Sales by Company (2018-2024) & (K Units)
Table 26. Global Norovirus Vaccine Sales Share by Company (2018-2024)
Table 27. Global Norovirus Vaccine Revenue by Company (2018-2024) & (US$ Million)
Table 28. Global Norovirus Vaccine Revenue Share by Company (2018-2024)
Table 29. Global Market Norovirus Vaccine Price by Company (2018-2024) & (US$/Unit)
Table 30. Global Norovirus Vaccine Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 31. Global Norovirus Vaccine Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 32. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Norovirus Vaccine as of 2022)
Table 33. Date of Key Manufacturers Enter into Norovirus Vaccine Market
Table 34. Key Manufacturers Norovirus Vaccine Product Type
Table 35. Mergers & Acquisitions, Expansion Plans
Table 36. Global Norovirus Vaccine Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 37. Global Norovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 38. Global Norovirus Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 39. Global Norovirus Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 40. Global Norovirus Vaccine Sales Market Share in Value by Region (2018-2024)
Table 41. Global Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 42. Global Norovirus Vaccine Sales by Region (2024-2029) & (K Units)
Table 43. Global Norovirus Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 44. Global Norovirus Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 45. Global Norovirus Vaccine Sales Market Share in Value by Region (2024-2029)
Table 46. Global Norovirus Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 47. Global Norovirus Vaccine Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 48. Global Norovirus Vaccine Sales by Application (2018-2024) & (K Units)
Table 49. Global Norovirus Vaccine Sales Market Share in Volume by Application (2018-2024)
Table 50. Global Norovirus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 51. Global Norovirus Vaccine Sales Market Share in Value by Application (2018-2024)
Table 52. Global Norovirus Vaccine Price by Application (2018-2024) & (US$/Unit)
Table 53. Global Norovirus Vaccine Sales by Application (2024-2029) & (K Units)
Table 54. Global Norovirus Vaccine Sales Market Share in Volume by Application (2024-2029)
Table 55. Global Norovirus Vaccine Sales by Application (2024-2029) & (US$ Million)
Table 56. Global Norovirus Vaccine Sales Market Share in Value by Application (2024-2029)
Table 57. Global Norovirus Vaccine Price by Application (2024-2029) & (US$/Unit)
Table 58. North America Norovirus Vaccine Sales by Application (2018-2024) (K Units)
Table 59. North America Norovirus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 60. Europe Norovirus Vaccine Sales by Application (2018-2024) (K Units)
Table 61. Europe Norovirus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 62. Asia-Pacific Norovirus Vaccine Sales by Application (2018-2024) (K Units)
Table 63. Asia-Pacific Norovirus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 64. Latin America Norovirus Vaccine Sales by Application (2018-2024) (K Units)
Table 65. Latin America Norovirus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 66. Middle East and Africa Norovirus Vaccine Sales by Application (2018-2024) (K Units)
Table 67. Middle East and Africa Norovirus Vaccine Sales by Application (2018-2024) & (US$ Million)
Table 68. North America Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 69. North America Norovirus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 70. North America Norovirus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 71. North America Norovirus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 72. North America Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 73. North America Norovirus Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 74. North America Norovirus Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 75. North America Norovirus Vaccine Sales Market Share in Value by Country (2024-2029)
Table 76. Europe Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 77. Europe Norovirus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 78. Europe Norovirus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 79. Europe Norovirus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 80. Europe Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 81. Europe Norovirus Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 82. Europe Norovirus Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 83. Europe Norovirus Vaccine Sales Market Share in Value by Country (2024-2029)
Table 84. Asia-Pacific Norovirus Vaccine Sales by Region (2018-2024) & (K Units)
Table 85. Asia-Pacific Norovirus Vaccine Sales Market Share in Volume by Region (2018-2024)
Table 86. Asia-Pacific Norovirus Vaccine Sales by Region (2018-2024) & (US$ Million)
Table 87. Asia-Pacific Norovirus Vaccine Sales Market Share in Value by Region (2018-2024)
Table 88. Asia-Pacific Norovirus Vaccine Sales by Region (2024-2029) & (K Units)
Table 89. Asia-Pacific Norovirus Vaccine Sales Market Share in Volume by Region (2024-2029)
Table 90. Asia-Pacific Norovirus Vaccine Sales by Region (2024-2029) & (US$ Million)
Table 91. Asia-Pacific Norovirus Vaccine Sales Market Share in Value by Region (2024-2029)
Table 92. Latin America Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 93. Latin America Norovirus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 94. Latin America Norovirus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 95. Latin America Norovirus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 96. Latin America Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 97. Latin America Norovirus Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 98. Latin America Norovirus Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 99. Latin America Norovirus Vaccine Sales Market Share in Value by Country (2024-2029)
Table 100. Middle East and Africa Norovirus Vaccine Sales by Country (2018-2024) & (K Units)
Table 101. Middle East and Africa Norovirus Vaccine Sales Market Share in Volume by Country (2018-2024)
Table 102. Middle East and Africa Norovirus Vaccine Sales by Country (2018-2024) & (US$ Million)
Table 103. Middle East and Africa Norovirus Vaccine Sales Market Share in Value by Country (2018-2024)
Table 104. Middle East and Africa Norovirus Vaccine Sales by Country (2024-2029) & (K Units)
Table 105. Middle East and Africa Norovirus Vaccine Sales Market Share in Volume by Country (2024-2029)
Table 106. Middle East and Africa Norovirus Vaccine Sales by Country (2024-2029) & (US$ Million)
Table 107. Middle East and Africa Norovirus Vaccine Sales Market Share in Value by Country (2024-2029)
Table 108. Hillevax Company Information
Table 109. Hillevax Introduction and Business Overview
Table 110. Hillevax Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 111. Hillevax Norovirus Vaccine Product
Table 112. Hillevax Recent Development
Table 113. Vaxart Company Information
Table 114. Vaxart Introduction and Business Overview
Table 115. Vaxart Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 116. Vaxart Norovirus Vaccine Product
Table 117. Vaxart Recent Development
Table 118. Moderna Company Information
Table 119. Moderna Introduction and Business Overview
Table 120. Moderna Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 121. Moderna Norovirus Vaccine Product
Table 122. Moderna Recent Development
Table 123. UMN Pharma Company Information
Table 124. UMN Pharma Introduction and Business Overview
Table 125. UMN Pharma Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 126. UMN Pharma Norovirus Vaccine Product
Table 127. UMN Pharma Recent Development
Table 128. Daiichi Sankyo Company Information
Table 129. Daiichi Sankyo Introduction and Business Overview
Table 130. Daiichi Sankyo Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 131. Daiichi Sankyo Norovirus Vaccine Product
Table 132. Daiichi Sankyo Recent Development
Table 133. Kanghua Biology Company Information
Table 134. Kanghua Biology Introduction and Business Overview
Table 135. Kanghua Biology Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 136. Kanghua Biology Norovirus Vaccine Product
Table 137. Kanghua Biology Recent Development
Table 138. Beijing Institute of Biological Products Company Information
Table 139. Beijing Institute of Biological Products Introduction and Business Overview
Table 140. Beijing Institute of Biological Products Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 141. Beijing Institute of Biological Products Norovirus Vaccine Product
Table 142. Beijing Institute of Biological Products Recent Development
Table 143. Zhifei Bio Company Information
Table 144. Zhifei Bio Introduction and Business Overview
Table 145. Zhifei Bio Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 146. Zhifei Bio Norovirus Vaccine Product
Table 147. Zhifei Bio Recent Development
Table 148. China Biotechnology Co., Ltd. Company Information
Table 149. China Biotechnology Co., Ltd. Introduction and Business Overview
Table 150. China Biotechnology Co., Ltd. Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 151. China Biotechnology Co., Ltd. Norovirus Vaccine Product
Table 152. China Biotechnology Co., Ltd. Recent Development
Table 153. North China Pharmaceutical Company Information
Table 154. North China Pharmaceutical Introduction and Business Overview
Table 155. North China Pharmaceutical Norovirus Vaccine Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 156. North China Pharmaceutical Norovirus Vaccine Product
Table 157. North China Pharmaceutical Recent Development
Table 158. Key Raw Materials Lists
Table 159. Raw Materials Key Suppliers Lists
Table 160. Norovirus Vaccine Market Trends
Table 161. Norovirus Vaccine Market Drivers
Table 162. Norovirus Vaccine Market Challenges
Table 163. Norovirus Vaccine Market Restraints
Table 164. Norovirus Vaccine Distributors List
Table 165. Norovirus Vaccine Downstream Customers
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources
List of Figures
Figure 1. Norovirus Vaccine Product Picture
Figure 2. Global Norovirus Vaccine Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Norovirus Vaccine Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Norovirus Vaccine Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Bivalent
Figure 6. Global Bivalent Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Quadrivalent
Figure 8. Global Quadrivalent Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Product Picture of Hexavalent
Figure 10. Global Hexavalent Sales YoY Growth (2018-2029) & (K Units)
Figure 11. Global Norovirus Vaccine Sales by Type (2018-2029) & (US$ Million)
Figure 12. Global Norovirus Vaccine Sales Market Share by Type in 2022 & 2029
Figure 13. North America Norovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 14. North America Norovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 15. Europe Norovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 16. Europe Norovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 17. Asia-Pacific Norovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 18. Asia-Pacific Norovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 19. Latin America Norovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 20. Latin America Norovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 21. Middle East and Africa Norovirus Vaccine Sales Market Share in Volume by Type in 2022
Figure 22. Middle East and Africa Norovirus Vaccine Sales Market Share in Value by Type in 2022
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Norovirus Vaccine Sales in 2022
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Norovirus Vaccine Revenue in 2022
Figure 25. Norovirus Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 26. Product Picture of Hospital
Figure 27. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Clinic
Figure 29. Global Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Norovirus Vaccine Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Norovirus Vaccine Sales Market Share by Application in 2022 & 2029
Figure 34. North America Norovirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 35. North America Norovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 36. Europe Norovirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 37. Europe Norovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Norovirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Norovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 40. Latin America Norovirus Vaccine Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Norovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Norovirus Vaccine Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Norovirus Vaccine Manufacturing Cost Structure
Figure 45. Norovirus Vaccine Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries